3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
10
Stomach Neoplasms
9
Neoplasm Metastasis
8
Breast Neoplasms
8
Esophageal Neoplasms
7
Colorectal Neoplasms
6
Small Cell Lung Carcinoma
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Anus Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Interventions
gallium Ga 68 dotatate
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Nivolumab
1
Eflornithine
1
Drug Therapy
1
CLR1404
1
Blood Specimen Collection
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Drug Therapy
×
90 days
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled